Archford Capital Strategies’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Archford Capital Strategies's EW Position: Q3 2019 in Review
Archford Capital Strategies sold out of Edwards Lifesciences (EW) in Q3 2019, closing a stake of 270 shares — an estimated $17K sold.
Archford Capital Strategies first reported a position in EW in Q1 2014 and held it in 17 quarters. The position peaked at $49K in Q3 2018. 964 funds tracked by Wall St. Rank hold EW as of Q3 2019.
- Archford Capital Strategies reported no remaining Edwards Lifesciences position as of Q3 2019 after selling out during the quarter.
- Archford Capital Strategies sold 270 Edwards Lifesciences shares in Q3 2019, an estimated $17K.
- Archford Capital Strategies first reported a position in Edwards Lifesciences in Q1 2014 and held it in 17 quarters.
- Archford Capital Strategies's Edwards Lifesciences position peaked at $49K in Q3 2018.
- 964 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.
Based on Archford Capital Strategies's 13F filing for Q3 2019, filed 23 Oct 2019.